ADSK
43
4
LLY
70
3
XRAY
16
2
BDX
55
4
ES
38
7
HD
31
-3
KLAC
59
3
WU
64
8
MUR
30
5
DG
50
10
NFLX
57
-2
GRMN
46
-3
L
59
13
ISRG
57
-3
BMY
56
5
VRSK
75
7
NOC
48
-2
F
56
4
ECL
67
3
GS
46
-2
ADSK
43
4
LLY
70
3
XRAY
16
2
BDX
55
4
ES
38
7
HD
31
-3
KLAC
59
3
WU
64
8
MUR
30
5
DG
50
10
NFLX
57
-2
GRMN
46
-3
L
59
13
ISRG
57
-3
BMY
56
5
VRSK
75
7
NOC
48
-2
F
56
4
ECL
67
3
GS
46
-2
Financhill
Back

Trip.com Group 10K Form

Buy
56

TCOM
Trip.com Group

Last Price:
$63.87
Seasonality Move:
13.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCOM News And Ratings

See the #1 stock for the next 7 days that we like better than TCOM

TCOM Financial Statistics

Sales & Book Value

Annual Sales: $7.4B
Cash Flow: $325.8M
Price / Cash Flow: 20.96
Annual Sales: $29.83
Price / Book: 2.14

Profitability

EPS (TTM): 3.48240
Net Income (TTM): $2.4B
Gross Margin: $6B
Return on Equity: 12.79%
Return on Assets: 7.2%

Trip.com Group Earnings Forecast

Key Trip.com Group Financial Ratios

  • The Gross Profit Margin over the past 25 years for TCOM is 81.25%.
  • The Selling, General & Administrative Expenses for TCOM have been equal to 30.00% of Gross Profit Margin.
  • The Research & Development expenses have been 24.65% of Revenue.
  • The Interest Expense is 10.17% of Operating Income.
  • The Net Earning history of TCOM is 32.02% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 18 years.

Trip.com Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Hotels, Restaurants & Leisure
Sector: Consumer Discretionary
Current Symbol: TCOM
Website: ctrip.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 1.51
Quick Ratio: 1.24

Price-to-Earnings

Trailing P/E Ratio: 18.48
Forward P/E Ratio: 15.75

TCOM Technical Analysis vs Fundamental Analysis

Buy
56
Trip.com Group (TCOM) is a Buy

Is Trip.com Group a Buy or a Sell?

  • Trip.com Group stock is rated a Buy
    The current Trip.com Group [TCOM] share price is $63.83. The Score for TCOM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.